Cargando…
Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
Renal cell carcinoma (RCC) is a lethal urological cancer, with incidence and mortality rates increasing by 2-3% per decade. The lack of standard screening tests contributes to the fact that one-third of patients are diagnosed with locally invasive or metastatic disease. Moreover, 20-40% of RCC patie...
Autores principales: | Teixeira, Ana L, Dias, Francisca, Gomes, Mónica, Fernandes, Mara, Medeiros, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345530/ https://www.ncbi.nlm.nih.gov/pubmed/28326253 http://dx.doi.org/10.15586/jkcvhl.2014.19 |
Ejemplares similares
-
MicroRNAs and Drug Resistance in Non-Small Cell Lung Cancer: Where Are We Now and Where Are We Going
por: Cuttano, Roberto, et al.
Publicado: (2022) -
MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?
por: Almeida, Beatriz, et al.
Publicado: (2023) -
Epilepsy and psychosis– where are we now?
por: Pereira, I., et al.
Publicado: (2021) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Where are we now?
Publicado: (1977)